My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 67

    1.

    Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells.

    Wan X, Liu J, Lu JF, Tzelepi V, Yang J, Starbuck MW, Diao L, Wang J, Efstathiou E, Vazquez ES, Troncoso P, Maity SN, Navone NM.

    Clin Cancer Res. 2012 Feb 1;18(3):726-36.

    PMID:
    22298898
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

    Lange T, Ullrich S, Müller I, Nentwich MF, Stübke K, Feldhaus S, Knies C, Hellwinkel OJ, Vessella RL, Abramjuk C, Anders M, Schröder-Schwarz J, Schlomm T, Huland H, Sauter G, Schumacher U.

    Clin Cancer Res. 2012 Mar 1;18(5):1364-73. Epub 2012 Jan 18.

    PMID:
    22261809
    [PubMed - in process]

    Related citations

    3.

    Modeling a lethal prostate cancer variant with small-cell carcinoma features.

    Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, Hoang A, Efstathiou E, Sircar K, Navone NM, Troncoso P, Liang S, Logothetis CJ, Maity SN, Aparicio AM.

    Clin Cancer Res. 2012 Feb 1;18(3):666-77. Epub 2011 Dec 12.

    PMID:
    22156612
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.

    Fraser M, Zhao H, Luoto KR, Lundin C, Coackley C, Chan N, Joshua AM, Bismar TA, Evans A, Helleday T, Bristow RG.

    Clin Cancer Res. 2012 Feb 15;18(4):1015-27. Epub 2011 Nov 23.

    PMID:
    22114138
    [PubMed - in process]

    Related citations

    5.

    NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.

    Locke JA, Zafarana G, Ishkanian AS, Milosevic M, Thoms J, Have CL, Malloff CA, Lam WL, Squire JA, Pintilie M, Sykes J, Ramnarine VR, Meng A, Ahmed O, Jurisica I, van der Kwast T, Bristow RG.

    Clin Cancer Res. 2012 Jan 1;18(1):308-16. Epub 2011 Nov 2.

    PMID:
    22048240
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics.

    Scher HI, Nasso SF, Rubin EH, Simon R.

    Clin Cancer Res. 2011 Nov 1;17(21):6634-40.

    PMID:
    22046024
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

    Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, Sgouros G, Mease RC, Pomper MG.

    Clin Cancer Res. 2011 Dec 15;17(24):7645-53. Epub 2011 Oct 31.

    PMID:
    22042970
    [PubMed - in process]

    Related citations

    8.

    Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

    Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S.

    Clin Cancer Res. 2011 Dec 15;17(24):7673-83. Epub 2011 Oct 28.

    PMID:
    22038995
    [PubMed - in process]

    Related citations

    9.

    GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.

    Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D.

    Clin Cancer Res. 2011 Nov 15;17(22):7174-82. Epub 2011 Sep 20.

    PMID:
    21933889
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.

    Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM.

    Clin Cancer Res. 2011 Oct 15;17(20):6563-73. Epub 2011 Aug 30.

    PMID:
    21878536
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.

    Chen L, Mooso BA, Jathal MK, Madhav A, Johnson SD, van Spyk E, Mikhailova M, Zierenberg-Ripoll A, Xue L, Vinall RL, deVere White RW, Ghosh PM.

    Clin Cancer Res. 2011 Oct 1;17(19):6218-28. Epub 2011 Aug 15.

    PMID:
    21844010
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants.

    Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery RB.

    Clin Cancer Res. 2011 Sep 15;17(18):5913-25. Epub 2011 Aug 1.

    PMID:
    21807635
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner S, Enodien M, Sirma H, Luebke AM, Krohn A, Mayer PS, Simon R, Tennstedt P, Müller J, Scholz L, Brase JC, Liu AY, Schlüter H, Pantel K, Schumacher U, Bokemeyer C, Steuber T, Graefen M, Sauter G, Schlomm T.

    Clin Cancer Res. 2011 Sep 15;17(18):5878-88. Epub 2011 Jul 26.

    PMID:
    21791629
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c.

    Saad F, Hotte S, North S, Eigl B, Chi K, Czaykowski P, Wood L, Pollak M, Berry S, Lattouf JB, Mukherjee SD, Gleave M, Winquist E; Canadian Uro-Oncology Group.

    Clin Cancer Res. 2011 Sep 1;17(17):5765-73. Epub 2011 Jul 25.

    PMID:
    21788353
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.

    Siddique HR, Mishra SK, Karnes RJ, Saleem M.

    Clin Cancer Res. 2011 Aug 15;17(16):5379-91. doi: 10.1158/1078-0432.CCR-11-0916. Epub 2011 Jun 28.

    PMID:
    21712449
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.

    Mohler JL, Titus MA, Wilson EM.

    Clin Cancer Res. 2011 Sep 15;17(18):5844-9. Epub 2011 Jun 24.

    PMID:
    21705451
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Prostate cancer immunotherapy.

    May KF Jr, Gulley JL, Drake CG, Dranoff G, Kantoff PW.

    Clin Cancer Res. 2011 Aug 15;17(16):5233-8. doi: 10.1158/1078-0432.CCR-10-3402. Epub 2011 Jun 23.

    PMID:
    21700764
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Circulating tumor cells as biomarkers in prostate cancer.

    Danila DC, Fleisher M, Scher HI.

    Clin Cancer Res. 2011 Jun 15;17(12):3903-12. Review.

    PMID:
    21680546
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Overcoming chemotherapy resistance in prostate cancer.

    Madan RA, Pal SK, Sartor O, Dahut WL.

    Clin Cancer Res. 2011 Jun 15;17(12):3892-902.

    PMID:
    21680545
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.

    Gulley JL, Drake CG.

    Clin Cancer Res. 2011 Jun 15;17(12):3884-91. Review.

    PMID:
    21680544
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk